Alpine Immune Sciences Inc Investor Event - ASN Kidney Week Transcript
Please standby. Welcome to the Alpine Immune Sciences investor call. Currently, all participants are in a listen-only mode. As a reminder, this event is being recorded. I would now like to introduce Temre Johnson, Senior Director of Investor Relations and Corporate Communications at Alpine. Ms. Johnson please go ahead.
Thank you, Cynthia. Good afternoon, and thank you to everyone for taking the time to join us today. With me on today's call from Alpine are: Dr. Mitchell Gold, Executive Chairman and Chief Executive Officer; Dr. Stanford Peng, President and Head of Research and Development; Paul Rickey, Chief Financial Officer; and Dr. Remy Durand, Chief Business Officer. Also participating in today's call are: Dr. James Tumlin, Professor from Emory University; and Dr. Jonathan Barratt from the University of Leicester.
Before I turn the call over to Mitch, I'd like to remind you that we'll be making forward-looking statements during today's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |